Association of elevated ACSL4 expression with impaired endometrial receptivity in endometriosis and restoration by ACSL4 inhibitor PRGL493
Journal of Reproductive Immunology · 2025
DOI: 10.1016/j.jri.2025.104630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2025. Verfasst von Lei Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic, The First Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Coenzyme A Ligases, Endometriosis, Endometrium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Liaoning Province.
Abstract (Originalsprache)
This study investigated the role of ACSL4 in endometrial receptivity disorders in endometriosis (EMs) and evaluated PRGL493, an ACSL4 inhibitor, as a potential therapeutic target. Bioinformatic analysis identified ACSL4 as a potential key regulator among ferroptosis and receptivity-related genes. Clinical samples from EMs patients showed significantly higher endometrial ACSL4 expression and lower receptivity marker expression (αVβ3, OPN, HOXA10) compared to controls. In a mouse EMs model, PRGL493 treatment reduced lesion volume, decreased lipid peroxidation, increased pinopode formation, and improved expression of receptivity markers. Similarly, in human endometrial organoids from EMs patients, PRGL493 ameliorated ultrastructural abnormalities, including mitochondrial condensation, decreased secretory granules, and endoplasmic reticulum expansion, and restored receptivity marker expression to levels comparable to the control. These findings demonstrate that ACSL4 overexpression is associated with endometrial receptivity disorders in EMs and that ACSL4 overexpression is a key pathological feature linked to endometrial receptivity impairment in EMs. Targeting ACSL4 with PRGL493 ameliorates receptivity defects, suggesting its therapeutic potential for EMs-associated infertility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecologic, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Department of Gynecologic, The First Affiliated Hospital of Dalian Medical University, Dalian, China. Electronic address: shangyuhong@dmu.edu.cn.
- Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: yangqing_sj@126.com.
Förderung
- Key Research and Development Program of Liaoning Province
Zitieren
APA
Xu, L., Wei, H., Shang, Y., & Yang, Q. (2025). Association of elevated ACSL4 expression with impaired endometrial receptivity in endometriosis and restoration by ACSL4 inhibitor PRGL493. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2025.104630
Vancouver
Xu L, Wei H, Shang Y, Yang Q. Association of elevated ACSL4 expression with impaired endometrial receptivity in endometriosis and restoration by ACSL4 inhibitor PRGL493. Journal of Reproductive Immunology. 2025. doi:10.1016/j.jri.2025.104630
BibTeX
@article{Xu2025,
author = {Xu, Lei and Wei, Hong and Shang, YuHong and Yang, Qing},
title = {Association of elevated ACSL4 expression with impaired endometrial receptivity in endometriosis and restoration by ACSL4 inhibitor PRGL493},
journal = {Journal of Reproductive Immunology},
year = {2025},
doi = {10.1016/j.jri.2025.104630}
}
EUVIMED